QQ客服 官方微博 反馈留言

浏览/检索结果: 共12条，第1-10条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial 期刊论文 LANCET ONCOLOGY, 2015, 卷号: 16, 期号: 4 作者:  Hu, Xi-Chun;  Zhang, Jian;  Xu, Bing-He;  Cai, Li;  Ragaz, Joseph 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/13 Gemcitabine with cisplatin or paclitaxel in metastatic triple-negative breast cancer 会议论文 作者:  Hu, Xichun;  Xu, Binghe;  Cai, Li;  Wang, Zhonghua;  Wang, Biyun 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19 Bevacizumab in Combination with Modified FOLFOX6 in Heavily Pretreated Patients with HER2/Neu-Negative Metastatic Breast Cancer: A Phase II Clinical Trial 期刊论文 PLOS ONE, 2015, 卷号: 10, 期号: 7 作者:  Li, Ting;  Wang, Biyun;  Wang, Zhonghua;  Ragaz, Joseph;  Zhang, Jian 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/19 Gemcitabine with cisplatin or paclitaxel in metastatic triple-negative breast cancer 会议论文 CANCER RESEARCH, 2015-05-01 作者:  Hu, Xichun;  Xu, Binghe;  Cai, Li;  Wang, Zhonghua;  Wang, Biyun 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 Gemcitabine with cisplatin or paclitaxel in metastatic triple-negative breast cancer 期刊论文 2015, 卷号: 75 作者:  Hu, Xichun;  Xu, Binghe;  Cai, Li;  Wang, Zhonghua;  Wang, Biyun 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/13 Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial 期刊论文 2015, 卷号: 16, 期号: 4, 页码: 436-446 作者:  Hu, Xi-Chun;  Zhang, Jian;  Xu, Bing-He;  Cai, Li;  Ragaz, Joseph 收藏  |  浏览/下载：9/0  |  提交时间：2020/01/13 Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretrnted patients with metastatic triple-negative breast cancer 期刊论文 INTERNATIONAL JOURNAL OF CANCER, 2014, 卷号: 135, 期号: 8 作者:  Hu, Xichun;  Zhang, Jian;  Xu, Binghe;  Jiang, Zefei;  Ragaz, Joseph 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19 apatinib  VEGFR2  metastatic breast cancer  triple negative   Breast cancer incidence among young women of urban China (Shanghai) and in Canada: Implications for prevention. 会议论文 作者:  Ragaz, Joseph;  Coldman, Andy;  Fox, Joel;  Wilson, Kenneth S.;  Shakeraneh, Shayan 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretrnted patients with metastatic triple-negative breast cancer 期刊论文 2014, 卷号: 135, 期号: 8, 页码: 1961-1969 作者:  Hu, Xichun;  Zhang, Jian;  Xu, Binghe;  Jiang, Zefei;  Ragaz, Joseph 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13 apatinib  VEGFR2  metastatic breast cancer  triple negative   The maximum standardized uptake value of F-18-FDG PET scan to determine prognosis of hormone- receptor positive metastatic breast cancer 期刊论文 BMC CANCER, 2013, 卷号: 13 作者:   收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 Metastatic breast cancer  Luminal subtype  PET/CT  SUVmax  Prognosis